Affiliation:
1. Department of Microbiology, Cornell University, Ithaca, New York 14853-8101
Abstract
ABSTRACT
Daptomycin is the first of a new class of cyclic lipopeptide antibiotics used against multidrug-resistant, gram-positive pathogens. The proposed mechanism of action involves disruption of the functional integrity of the bacterial membrane in a Ca
2+
-dependent manner. We have used transcriptional profiling to demonstrate that treatment of
Bacillus subtilis
with daptomycin strongly induces the
lia
operon including the autoregulatory LiaRS two-component system (homologous to
Staphylococcus aureus
VraSR). The
lia
operon protects against daptomycin, and deletion of
liaH
, encoding a phage-shock protein A (PspA)-like protein, leads to threefold increased susceptibility. Since daptomycin interacts with the membrane, we tested mutants with altered membrane composition for effects on susceptibility. Deletion mutations of
mprF
(lacking lysyl-phosphatidylglycerol) or
des
(lipid desaturase) increased daptomycin susceptibility, whereas overexpression of MprF decreased susceptibility. Conversely, depletion of the cell for the anionic lipid phosphatidylglycerol led to increased resistance. Fluorescently labeled daptomycin localized to the septa and in a helical pattern around the cell envelope and was delocalized upon the depletion of phosphatidylglycerol. Together, these results indicate that the daptomycin-Ca
2+
complex interacts preferentially with regions enriched in anionic phospholipids and leads to membrane stresses that can be ameliorated by PspA family proteins.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Cited by
148 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献